[3‐(2‐Chloro­phen­yl)‐1,2,4‐oxadiazol‐5‐yl]methanol

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-5368|62|7|o3007-o3008

ISSN： 1600-5368

Source： Acta Crystallographica Section E, Vol.62, Iss.7, 2006-07, pp. : o3007-o3008

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

[3‐(4‐Chloro­phen­yl)‐1,2,4‐oxadiazol‐5‐yl]methanol

By  

Acta Crystallographica Section E, Vol. 62, Iss. 10, 2006-10 ,pp. : o4226-o4227

John Wiley & Sons Inc

Access to resources Recommend Favorite

2‐[3‐(4‐Chloro­phen­yl)‐1,2,4‐oxadiazol‐5‐yl]phenol

By  

Acta Crystallographica Section E, Vol. 62, Iss. 12, 2006-12 ,pp. : o5592-o5593

John Wiley & Sons Inc

Access to resources Recommend Favorite

2‐{2‐[3‐(2‐Chloro­phen­yl)‐1,2,4‐oxadiazol‐5‐yl]phen­oxy}‐N‐(2,6‐dimethyl­phen­yl)acetamide

By  

Acta Crystallographica Section E, Vol. 62, Iss. 11, 2006-11 ,pp. : o5280-o5281

John Wiley & Sons Inc

Access to resources Recommend Favorite

2‐{2‐[3‐(4‐Chloro­phen­yl)‐1,2,4‐oxadiazol‐5‐yl]phen­oxy}‐N‐(2,6‐dimethyl­phen­yl)acetamide

By  

Acta Crystallographica Section E, Vol. 62, Iss. 10, 2006-10 ,pp. : o4744-o4745

John Wiley & Sons Inc

Access to resources Recommend Favorite

N‐(2,6‐Dimethyl­phen­yl)‐2‐{2‐[3‐(3‐methoxy­phen­yl)‐1,2,4‐oxadiazol‐5‐yl]phen­oxy}acetamide

By  

Acta Crystallographica Section E, Vol. 62, Iss. 12, 2006-12 ,pp. : o5574-o5575

John Wiley & Sons Inc

Access to resources Recommend Favorite